Eli Lilly has its first approval for oral GLP-1 agonist orforglipron, in the US, where it will compete with Novo Nordisk's ...
The 2026 agenda is anchored by a distinguished roster of speakers who are actively redefining the boundaries of science, ...
In a subgroup of black women enrolled in a US breast cancer registry called BEST, women deemed to have low-risk tumours using the MammaPrint test had a 97.7% recurrence-free rate after 10 years, the ...
At the LSX World Congress in Lisbon this year, web editor Nicole Raleigh stepped aside from the hustle and bustle to speak ...
"Through the integration of virtual control groups, EMA also seeks to improve the relevance and predictability of ...
Three behavioural phenomena are particularly consequential in screening and prevention research: ...
The FDA has ramped up the pressure on Amgen to withdraw Tavneos for a rare vasculitis condition from the market, with a ...
Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...
Mitapivat has been approved in the US under the Pyrukynd trade name since 2022 as a treatment for haemolytic anaemia in ...
The NHS in England will make Novo Nordisk's Wegovy available to around 1.2 million people in order to reduce their risk of ...
In a new episode of the pharmaphorum podcast, recorded at BIO-Europe Spring in Lisbon, Portugal, web editor Nicole Raleigh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results